Jun 2026 (Q2 FY26) — Aug 5, 2026
Solventum Q2 FY26 — Strong Performance and Strategic Portfolio Optimization
Read the full callSolventum (SOLV) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Solventum earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,209 | +2.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 8.2 | −1.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 92.0 | +2.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
11 of 12 judged targets kept · 16 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year adjusted (non-GAAP) EPS | $6.40 to $6.60 | Dec 2025 | we are raising our earnings per share guide to $7.10 to $7.20 versus our prior range of $6.40 to $6.60. | Revised Up |
| Full-year effective tax rate | 19.5% to 20.5% | Dec 2025 | a tax rate in the range of 19.5% to 20.5% are both unchanged. | On Track |
1 of Solventum Corp's 28 targets was missed. See which ones, and which are quietly gone. The 2 above are the free sample; 26 more targets are in the full ledger.
Claimed
- Organic sales growth of 9.5% reported, or 4% normalized for ERP advanced orders, exceeding expectations.
- Adjusted EPS of $2.55, including $0.34 from advanced orders and $0.48 from tariff refund, ahead of expectations.
- Gross margins increased by 410 basis points to 60.1% (55.6% excluding tariff refund), driven by programmatic savings.
- Acera acquisition continues to perform strongly with over 40% year-over-year revenue growth and over 80% gross margin.
- Share repurchase program accelerated, with $288 million used to repurchase nearly 4 million shares in the quarter.
Qualified
- ERP advanced orders of approximately $125 million in Q2 will mostly reverse in Q3, leading to an expected Q3 sales decline of -3% to -4%.
- Tariff impact of 150 basis points on gross margins, partially offset by programmatic savings.
- Litigation costs of $157 million (net of $55 million insurance proceeds) recorded, excluded from non-GAAP results.
Price
$87.86 +0.69% · +$0.6
Performance +22.9% 1Y
1Y: $71.49 on 14 Oct 2025 → $87.86. High $92.44 (3 Sept 2026), low $62.49 (7 Apr 2026).
- Previous close
- $87.26
- 52-week range
- $62.49 – $92.44
- One year
- +22.78%
Overview
- Symbol
- SOLV
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
11 of 12 judged targets kept · 16 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year adjusted (non-GAAP) EPS | $6.40 to $6.60 | Dec 2025 | we are raising our earnings per share guide to $7.10 to $7.20 versus our prior range of $6.40 to $6.60. | Revised Up |
| Full-year effective tax rate | 19.5% to 20.5% | Dec 2025 | a tax rate in the range of 19.5% to 20.5% are both unchanged. | On Track |
Claimed
- Organic sales growth of 9.5% reported, or 4% normalized for ERP advanced orders, exceeding expectations.
- Adjusted EPS of $2.55, including $0.34 from advanced orders and $0.48 from tariff refund, ahead of expectations.
- Gross margins increased by 410 basis points to 60.1% (55.6% excluding tariff refund), driven by programmatic savings.
- Acera acquisition continues to perform strongly with over 40% year-over-year revenue growth and over 80% gross margin.
- Share repurchase program accelerated, with $288 million used to repurchase nearly 4 million shares in the quarter.
Qualified
- ERP advanced orders of approximately $125 million in Q2 will mostly reverse in Q3, leading to an expected Q3 sales decline of -3% to -4%.
- Tariff impact of 150 basis points on gross margins, partially offset by programmatic savings.
- Litigation costs of $157 million (net of $55 million insurance proceeds) recorded, excluded from non-GAAP results.
The full ledger
Open Solventum Corp’s full ledger
A free account opens 5 company ledgers a month. All 28 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 5, 2026
Solventum Q1 FY26 — Strong Start, Ahead of Plan, Accelerated Buybacks
Read the full callDec 2025 (Q4 FY25) — Feb 26, 2026
Solventum Q4 FY25 — Strong Sales Growth and Accelerated Portfolio Optimization
Read the full callEvery analysed call
Solventum earnings calls (SOLV)
Financials
What the filings say
Net profit, year on year: +2% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,082 | 2,075 | 2,070 | 2,161 | 2,096 | 1,998 | 2,007 | 2,209 |
| Expenses | 1,807 | — | — | — | — | — | — | — |
| Operating profit | 275 | 136 | 152 | 214 | 1,690 | 125 | 81 | 181 |
| Operating margin | 13.2% | 6.5% | 7.3% | 9.9% | 80.6% | 6.3% | 4.0% | 8.2% |
| Profit before tax | 167 | 13 | 38 | 103 | 1,514 | 58 | 16 | 108 |
| Tax rate | 26.9% | −130.8% | −260.5% | 12.6% | 16.4% | −8.6% | 18.8% | 13.9% |
| Net profit | 122 | 31 | 137 | 90 | 1,266 | 63 | 13 | 92 |
| EPS ($ per share) | 0.70 | — | 0.79 | 0.52 | 7.26 | — | 0.07 | 0.53 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Equity capital | — | 0 | 2 | 2 |
| Reserves | — | 0 | 242 | 1,797 |
| Total liabilities | — | 2,277 | 11,498 | 9,245 |
| Fixed assets | — | 1,457 | 1,622 | 1,326 |
| Total assets | — | 13,943 | 14,457 | 14,294 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash from operations | 1,679 | 1,915 | 1,185 | 369 |
| Cash from investing | -253 | -230 | -380 | 2,797 |
| Cash from financing | -1,460 | -1,552 | -240 | -3,057 |
| Net cash flow | -30 | 133 | 568 | 116 |
| Capital expenditure | -251 | -290 | -380 | -379 |
| Free cash flow | 1,428 | 1,625 | 805 | -10 |
SOLV revenue by segment
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Med Surg | 57% | 57% | 56% | 56% | 58% | 62% | 61% | 62% | +12.6% |
| Dental Solutions | 15% | 15% | 16% | 16% | 16% | 17% | 18% | 18% | +17.2% |
| Health Information Systems | 16% | 16% | 16% | 16% | 16% | 17% | 17% | 16% | +4.4% |
| Purification and Filtration | 11% | 11% | 12% | 12% | 6% | -6% | 0% | 0% | -100.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
SOLV operating KPIs by quarter
| KPI | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Change vs prior quarter |
|---|---|---|---|
| Distribution centers | 55Regarding supply chain, we've taken further steps to separate from 3M and have now reduced our distribution center network to 55 locations, progressing towards our goal of 45.Source: earnings call transcript | 54With further work to streamline our distribution centers, we are now down to 54 worldwide.Source: earnings call transcript | -1.8% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
63 filings between Dec 1, 2025 and Sep 1, 2026.
Open market
decisions to buy or sellPurchases
$100.3K
1 purchase by 1 insider
Sales
None
No insider sold shares.
Compensation
not trading decisions- 42
- Option exercise — converted options into shares
- 20
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Wendell Amy McBride | $100.3K | — | Mar 10, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Hanson Bryan C Chief Executive Officer | Option exercise | 67,261 | — |
| Sep 1, 2026 | Hanson Bryan C Chief Executive Officer | Tax withheld | 26,468 | $2.41M |
| May 13, 2026 | Landucci Amy Chief Information Officer | Tax withheld | 2,017 | $150.1K |
| May 13, 2026 | Kirberger Marcela A. Chief Legal Affairs Officer | Option exercise | 4,488 | $0 |
| May 13, 2026 | Wilcox Mary T Chief Accounting Officer | Tax withheld | 728 | $54.2K |
| May 13, 2026 | Gomez Tammy L Chief Human Resources Officer | Option exercise | 3,960 | $0 |
| May 13, 2026 | McMillan Wayde D. Chief Financial Officer | Option exercise | 9,503 | $0 |
| May 13, 2026 | Hanson Bryan C Chief Executive Officer | Option exercise | 34,315 | $0 |
| May 13, 2026 | Kirberger Marcela A. Chief Legal Affairs Officer | Tax withheld | 1,952 | $145.2K |
| May 13, 2026 | Harrington Paul S Chief Supply Chain Officer | Tax withheld | 1,678 | $124.9K |
| May 13, 2026 | Harrington Paul S Chief Supply Chain Officer | Option exercise | 3,960 | $0 |
| May 13, 2026 | McMillan Wayde D. Chief Financial Officer | Tax withheld | 4,404 | $327.7K |
| May 13, 2026 | Hanson Bryan C Chief Executive Officer | Tax withheld | 13,503 | $1.00M |
| May 13, 2026 | Gomez Tammy L Chief Human Resources Officer | Tax withheld | 1,668 | $124.1K |
| May 13, 2026 | Wilcox Mary T Chief Accounting Officer | Option exercise | 2,376 | $0 |
| May 13, 2026 | Landucci Amy Chief Information Officer | Option exercise | 4,422 | $0 |
| Apr 30, 2026 | Wilson Darryl L. Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | DeVore Susan D. Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | Mily Elizabeth Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | ALBAN CARLOS Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | Wendell Amy McBride Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | Harris Bernard A Jr Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | EISENBERG GLENN A Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | WEILAND JOHN H Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | MAY KAREN J Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | Edwards Shirley Ann Director | Option exercise | 3,403 | $0 |
| Apr 30, 2026 | COX CARRIE SMITH Director | Option exercise | 4,916 | $0 |
| Mar 27, 2026 | Wendell Amy McBride Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | Harris Bernard A Jr Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | EISENBERG GLENN A Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | WEILAND JOHN H Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | MAY KAREN J Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | COX CARRIE SMITH Director | Option exercise | 6,336 | $0 |
| Mar 27, 2026 | Edwards Shirley Ann Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | Wilcox Mary T Chief Accounting Officer | Option exercise | 5,199 | $0 |
| Mar 27, 2026 | DeVore Susan D. Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | Mily Elizabeth Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | Wilcox Mary T Chief Accounting Officer | Tax withheld | 1,591 | $99.9K |
| Mar 27, 2026 | Wilson Darryl L. Director | Option exercise | 1,980 | $0 |
| Mar 27, 2026 | ALBAN CARLOS Director | Option exercise | 1,980 | $0 |
| Mar 10, 2026 | Wendell Amy McBride Director | Purchase | 1,475 | $100.3K |
| Mar 6, 2026 | Hanson Bryan C Chief Executive Officer | Tax withheld | 10,395 | $721.5K |
| Mar 6, 2026 | Hanson Bryan C Chief Executive Officer | Option exercise | 31,907 | $0 |
| Mar 6, 2026 | Kirberger Marcela A. Chief Legal Affairs Officer | Option exercise | 4,180 | $0 |
| Mar 6, 2026 | McMillan Wayde D. Chief Financial Officer | Tax withheld | 2,786 | $193.4K |
| Mar 6, 2026 | Harrington Paul S Chief Supply Chain Officer | Tax withheld | 1,073 | $74.5K |
| Mar 6, 2026 | Harrington Paul S Chief Supply Chain Officer | Option exercise | 3,300 | $0 |
| Mar 6, 2026 | Landucci Amy Chief Information Officer | Tax withheld | 1,731 | $120.1K |
| Mar 6, 2026 | Landucci Amy Chief Information Officer | Option exercise | 3,795 | $0 |
| Mar 6, 2026 | Gomez Tammy L Chief Human Resources Officer | Tax withheld | 895 | $62.1K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Solventum Corp
Free account. Everything above stays public.
Write why you follow Solventum Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading